DBV Technologies logo

Senior Statistical Programmer/Biostatistician

DBV Technologies

Warren, NJHybridPosted 1 day ago$150,000 - $185,000/year
Full TimeSenior LevelBioinformatics & Data ScienceBiotechnology
Original posting ↗

Summary

Provide hands-on biostatistical and statistical programming support within Biometrics for clinical development and Medical Affairs evidence-generation activities. This individual-contributor role combines applied statistical expertise with strong SAS programming skills to contribute to study design, develop statistical analysis plans, conduct and interpret analyses, and deliver reproducible, high-quality results.

Job description

Description

Provide hands-on biostatistical and statistical programming support within Biometrics for clinical development and Medical Affairs evidence-generation activities. This individual-contributor role combines applied statistical expertise with strong SAS programming skills to contribute to study design, develop statistical analysis plans, conduct and interpret analyses, and deliver reproducible, high-quality results.

In collaboration with senior biostatisticians and cross-functional colleagues, this role supports clinical study reporting, post-hoc and integrated analyses, publications, congress presentations, and medical information requests, ensuring consistency with regulatory analyses and appropriate communication of the evidence and its limitations.

Key Responsibilities

  • Contribute to clinical study design, endpoint selection, estimand definition, sample size calculations, and assessment of statistical assumptions in collaboration with senior biostatisticians and clinical colleagues.
  • Develop and review Statistical Analysis Plans (SAPs), analysis specifications, and table, listing, and figure shells, defining analysis populations, statistical methods, missing-data approaches, and sensitivity analyses with appropriate senior review.
  • Conduct and interpret efficacy and safety analyses, including prespecified, post-hoc, subgroup, integrated, and descriptive analyses; explain findings, assumptions, uncertainty, and limitations to statistical and non-statistical audiences.
  • Develop, validate, and review SAS programs, SDTM/ADaM datasets, analysis specifications, and supporting documentation; review SDTM inputs and ensure traceability from source data through analysis results.
  • Support Medical Affairs evidence needs through analyses and statistical input for manuscripts, congress abstracts and presentations, medical information responses, and data-on-file materials, under senior statistical guidance and applicable review processes.
  • Contribute statistical methods, results interpretation, and responses to review comments for clinical study reports, publications, and regulatory deliverables; support review of Define.xml and submission documentation as needed.
  • Perform independent quality control of analysis datasets, statistical programs, and results; investigate discrepancies and maintain reproducible workflows, clear documentation, and consistency across study, regulatory, and medical-use analyses.
  • Produce and validate Tables, Listings, and Figures (TLFs), including clear graphical displays that accurately communicate clinical findings; develop reusable programming tools to improve analytical efficiency and quality.
  • Collaborate with Biometrics, Clinical, Medical Affairs, Regulatory, and CRO partners to clarify analytical questions, review deliverables, and meet agreed timelines; escalate methodological or data-quality issues and ensure conclusions remain supported by the evidence.

Qualifications

  • Master's degree (MSc) or PhD in Biostatistics, Statistics, or a closely related quantitative field, with substantial training in statistical theory and applied clinical trial methods.
  • Typically 5–8 years of relevant biopharmaceutical or CRO experience combining applied biostatistics and hands-on statistical programming, with demonstrated responsibility for analysis planning, implementation, and interpretation of clinical trial results.
  • Desirable: Experience supporting clinical study reports or regulatory submissions and collaborating with CRO partners.
  • Preferred: Experience with publications, congress presentations, or Medical Affairs analyses.
  • Plus: Allergy, immunology, or pediatric study experience.
  • This is a hands-on individual-contributor position and does not require prior departmental leadership, commercial launch ownership, or people-management experience.
  • Strong hands-on SAS programming expertise, including DATA step processing, SQL, macros, statistical procedures, and graphics; ability to independently implement and validate statistical analyses. R proficiency is desirable.
  • Strong knowledge of CDISC ADaM standards and analysis dataset design, with working knowledge of SDTM, metadata, derivation specifications, and traceability to support reliable analyses and submission-ready deliverables.
  • Ability to translate clinical and scientific questions into appropriate analysis approaches, specifications, and TLFs; familiarity with clinical trial reporting requirements and statistical principles relevant to regulatory submissions.
  • Experience with independent programming validation, reproducible analytical workflows, version control, and documentation; familiarity with Pinnacle 21 or similar CDISC validation tools is desirable.
  • Proficiency in applying artificial intelligence (AI) methods and tools to code development and dataset validation, with the ability to use AI-assisted workflows to improve accuracy, speed, and efficiency in the production and quality control (QC) of statistical outputs, while maintaining independent verification, reproducibility, and data confidentiality.
  • Strong foundation in clinical trial statistics, including hypothesis testing, estimation and confidence intervals, regression and generalized linear models, longitudinal and time-to-event analyses, multiplicity, missing data, and sensitivity analyses; sound judgment in selecting methods and interpreting exploratory findings.
  • Fluent English (written and spoken), with the ability to explain statistical concepts and limitations clearly, contribute to scientific writing, and collaborate effectively with multidisciplinary teams.

Behavioral Skills

  • Curiosity: Keep on exploring uncharted territories. Always ask "why?" and more importantly "why not?"
  • Courage: Take smart risks, mentor each other to always do better & be accountable for our choices, our opinions, and our actions.
  • Collaboration: Teamwork and spirit. Support each other and be equally involved in the achievement of our common goals.
  • Credibility: Be transparent, follow through and build trust. Educate ourselves about our unique technology.

Requirements

  • Master's degree (MSc) or PhD in Biostatistics, Statistics, or a closely related quantitative field
  • Typically 5–8 years of relevant biopharmaceutical or CRO experience
  • Strong hands-on SAS programming expertise including DATA step processing, SQL, macros, statistical procedures, and graphics
  • Strong knowledge of CDISC ADaM standards and analysis dataset design
  • Working knowledge of SDTM, metadata, derivation specifications, and traceability
  • Strong foundation in clinical trial statistics including hypothesis testing, regression, longitudinal and time-to-event analyses, multiplicity, missing data, and sensitivity analyses
  • Fluent English (written and spoken)
  • Experience with independent programming validation, reproducible analytical workflows, version control, and documentation
  • Ability to translate clinical and scientific questions into appropriate analysis approaches, specifications, and TLFs
  • Proficiency in applying AI methods and tools to code development and dataset validation

Benefits

  • Hybrid work (3 days onsite)
  • Salary range $150-185k

Company overview

DBV Technologies is a global clinical-stage biopharmaceutical company pioneering epicutaneous immunotherapy (EPIT) through its innovative Viaskin™ patch technology platform. Founded by pediatricians in 2002, the company is dedicated to developing safe and effective treatments for food allergies and immunologic diseases with significant unmet medical needs. DBV's core technology involves delivering biologically active compounds through intact skin to re-educate the immune system, offering a non-invasive alternative to traditional allergy treatments. The company's primary focus is on developing the Viaskin peanut patch for pediatric patients with peanut allergy, with ongoing Phase 3 clinical trials across different age groups. Headquartered in Châtillon, France, with operations in Warren, New Jersey, DBV maintains a global presence and is publicly traded on Euronext Paris and Nasdaq. The company's pipeline also includes programs for cow's milk allergy, eosinophilic esophagitis, autoimmune disorders, and vaccine applications, demonstrating the broad potential of its patch-based immunotherapy platform.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.